Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J.M. Vrigneaud"'
Autor:
Claire Bernhard, Alexandra Oudot, Bertrand Collin, Pierre-Simon Bellaye, Mathieu Moreau, D. Vandroux, A. Cochet, L. Dumont, Franck Denat, O. Raguin, J.M. Vrigneaud, F. Brunotte
Publikováno v:
Clinical and Translational Oncology
Clinical and Translational Oncology, 2018, 〈10.1007/s12094-018-1886-4〉
Clinical & Translational Oncology
Clinical and Translational Oncology, Springer, 2018, 20 (12), pp.1557-1570. ⟨10.1007/s12094-018-1886-4⟩
Clinical and Translational Oncology, 2018, 〈10.1007/s12094-018-1886-4〉
Clinical & Translational Oncology
Clinical and Translational Oncology, Springer, 2018, 20 (12), pp.1557-1570. ⟨10.1007/s12094-018-1886-4⟩
Purpose This study aimed to investigate theranostic strategies in colorectal and skin cancer based on fragments of cetuximab, an anti-EGFR mAb, labeled with radionuclide with imaging and therapeutic properties, 111In and 177Lu, respectively. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19bb86f3963b2a46376b7bb4bc7d1af5
https://hal.archives-ouvertes.fr/hal-01802320
https://hal.archives-ouvertes.fr/hal-01802320
Autor:
Pierre Fumoleau, P-S Bellaye, Alexandra Oudot, O. Raguin, L. Dumont, A Savina, François Brunotte, J.M. Vrigneaud, Bertrand Collin, F Bouquet, Claire Bernhard
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2018, 78 (4 Supplement), pp.P5-01-03-P5-01-03. ⟨10.1158/1538-7445.SABCS17-P5-01-03⟩
Cancer Research, American Association for Cancer Research, 2018, 78 (4 Supplement), pp.P5-01-03-P5-01-03. ⟨10.1158/1538-7445.SABCS17-P5-01-03⟩
Introduction: HER2 is positive in approximately 20-30% of all breast cancer and is associated with poor prognosis, higher mortality and higher metastatic incidence. Current diagnosis of HER2 expression relies on invasive methods requiring tissue biop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3dc929555c10880f07875edfa1819a8
https://hal.archives-ouvertes.fr/hal-01794241
https://hal.archives-ouvertes.fr/hal-01794241
Autor:
V. Blaise, J.M. Vrigneaud
Publikováno v:
Physica Medica
Physica Medica, Elsevier, 2017, 44, ⟨10.1016/j.ejmp.2017.10.061⟩
Physica Medica, Elsevier, 2017, 44, ⟨10.1016/j.ejmp.2017.10.061⟩
Introduction During the simulation step of a selective internal radiation therapy (SIRT) with yttrium-90, SPECT/CT images using 99mTc-MAA (macroaggregated human albumin) are acquired in order to assess the lung shunt and the MAA biodistribution in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ee53dfee03b0d0787076acf57ac1ad
https://hal.archives-ouvertes.fr/hal-01794960
https://hal.archives-ouvertes.fr/hal-01794960
Publikováno v:
Biomedical Physics & Engineering Express
Biomedical Physics & Engineering Express, IOP Publishing, 2017, ⟨10.1088/2057-1976/aa686d⟩
Biomedical Physics & Engineering Express, 2017, 〈http://iopscience.iop.org/article/10.1088/2057-1976/aa686d〉. 〈10.1088/2057-1976/aa686d〉
Biomedical Physics & Engineering Express, IOP Publishing, 2017, ⟨10.1088/2057-1976/aa686d⟩
Biomedical Physics & Engineering Express, 2017, 〈http://iopscience.iop.org/article/10.1088/2057-1976/aa686d〉. 〈10.1088/2057-1976/aa686d〉
International audience; The LabPET/MR imaging system is a new preclinical prototype with sequentially-acquired PET/MR scan capabilities. The dual modality system is composed of a modified APD-based LabPET4 subsystem, coupled with a cryogen-free super
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0525603a8153f7d0b07563c6d1be525d
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01516033
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01516033
Autor:
I. Bessiéres, J.M. Vrigneaud
Publikováno v:
Physica Medica
Physica Medica, Elsevier, 2016, 32, pp.350-351. ⟨10.1016/j.ejmp.2016.11.071⟩
Physica Medica, 2016, 32, pp.350-351. ⟨10.1016/j.ejmp.2016.11.071⟩
Physica Medica, Elsevier, 2016, 32, pp.350-351. ⟨10.1016/j.ejmp.2016.11.071⟩
Physica Medica, 2016, 32, pp.350-351. ⟨10.1016/j.ejmp.2016.11.071⟩
Introduction In France, it is required to give patients some radiation safety advice following an iodine-131 therapy of thyroid. However, there is no regulatory methodology proposed to assess the restriction times required to limit radiation dose rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9cc6f1e62ffb5c3a01f6b954a6f6c3
https://hal.archives-ouvertes.fr/hal-01794959
https://hal.archives-ouvertes.fr/hal-01794959
Publikováno v:
Physica Medica. 32:351
This work aims to complete the dosimetric information available in the report No. 19-2001 of the French Society of Medical Physics (FSMP). This work is designed to help nuclear medicine professionals in the assessment of patient dose during diagnosti
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal de Radiologie. 89:1223-1224
Objectifs Comparer l’irradiation a la thyroide lors de la realisation d’un arthroscanner en position neutre et en position aber. Evaluer si l’utilisation de la modulation de la charge (dom) a un interet. Materiels et methodes Quinze patients av
Autor:
François Brunotte, Franck Denat, Bertrand Collin, N. Varoqueaux, O. Raguin, Alexandra Oudot, Pierre Fumoleau, Mathieu Moreau, Xavier Tizon, J.M. Vrigneaud, Olivier Duchamp
Publikováno v:
Cancer Research. 72:P4-02
Introduction: The accurate and reliable assessment of HER2 status is an essential step in the diagnostic workup and selection of targeted treatment strategy in breast cancer patients. However, current ex vivo methods do not evaluate HER2 status possi
Autor:
F. Brunotte, Franck Denat, Mathieu Moreau, Pierre Fumoleau, B. Collin, O. Duchamp, Alexandra Oudot, N. Varoqueaux, J.M. Vrigneaud, O. Raguin
Publikováno v:
European Journal of Cancer. 48:161